multidrugresist
gramneg
pathogen
enhanc
measur
need
prevent
spread
organ
greater
understand
mode
spread
acquisit
organ
essenti
effect
control
problem
report
case
infect
almost
complet
resist
gramneg
organ
case
expand
known
geograph
spread
organ
resist
problem
case
also
underscor
import
studi
epidemiolog
antimicrobi
drug
resist
gramneg
organ
rural
set
well
larg
metropolitan
center
dissemin
knowledg
regard
appropri
antimicrobi
drug
suscept
test
resist
organ
also
need
editor
newli
identifi
human
bocaviru
hbov
member
parvoviru
famili
suspect
infect
cell
respiratori
tract
thu
may
etiolog
agent
respiratori
diseas
human
although
koch
postul
fulfil
hbov
appear
like
caus
substanti
number
respiratori
tract
infect
least
children
describ
case
sever
atyp
pneumonia
associ
hbov
dna
bronchoalveolar
lavag
bal
sampl
adult
patient
caucasian
woman
angioimmunoblast
tnonhodgkin
lymphoma
nhl
chang
highli
malign
blastic
bcell
lymphoma
tcellrich
bnhl
state
cell
initi
stage
iiib
patient
previous
treat
vincristin
prednison
follow
chemotherapi
accord
protocol
cycl
novemb
januari
januari
februari
chemotherapi
combin
antimicrobi
drug
therapi
accord
rdhap
protocol
includ
dexamethason
chemotherapi
drug
cytarabin
cisplatin
monoclon
antibodi
drug
rituximab
persist
symptom
bcell
lymphoma
regimen
follow
therapi
switch
alemtuzumab
ifosfamid
carboplatin
hemorrhag
cystiti
occur
juli
patient
ongo
high
fever
aplasia
bone
marrow
unclear
etiolog
juli
hospit
treatment
initi
consist
antimicrobi
drug
treatment
ceftriaxon
mg
daili
gentamicin
mg
daili
antimycot
therapi
start
caspofungin
mg
daili
sinc
cytomegaloviru
cmv
infect
suspect
ganciclovir
mg
twice
daili
administ
iv
week
although
patient
report
ongo
cough
pneumonialik
symptom
sever
atyp
pneumonia
refract
antibacteri
antimycot
treatment
diagnos
first
time
hospit
treatment
comput
tomographi
scan
show
bilater
atyp
reticulonodular
infiltr
predomin
lower
zone
lung
figur
bal
obtain
exacerb
pulmonari
symptom
test
mycobacterium
tuberculosi
chlamydia
pneumonia
pneumocysti
jirovecii
aspergillu
sp
candida
sp
cryptococcu
neoforman
cmv
epsteinbarr
viru
hepat
b
viru
hepat
c
viru
hiv
herp
simplex
viru
varicellazost
viru
pcr
cultur
cultiv
result
neg
except
temporarili
weak
reactiv
aspergillu
antigen
serum
cmv
dna
peripher
blood
lymphocyt
posit
becam
neg
ganciclovir
therapi
archiv
portion
bal
assay
retrospect
pcrrevers
transcriptasepcr
human
bocaviru
respiratori
syncyti
viru
human
coronavirus
includ
sever
acut
respiratori
syndromeassoci
coronaviru
influenza
viru
human
metapneumoviru
hmpv
posit
result
obtain
human
bocaviru
confirm
sequenc
analysi
pcr
product
within
day
patient
symptom
decreas
discharg
hospit
day
despit
ongo
bone
marrow
aplasia
antimicrobi
antimycot
prophylaxi
includ
trimethoprim
sulfamethoxazol
mg
daili
voriconazol
mg
twice
daili
clinic
observ
led
primari
assumpt
fever
cough
pulmonari
symptom
like
caus
postchemotherapeut
extend
bone
marrow
aplasia
cmv
infect
accompani
unclear
bacteri
fungustyp
infect
retrospect
howev
human
bocaviru
dna
archiv
bal
strongli
suggest
pulmonari
symptom
caus
agent
rather
yet
unknown
bacteri
fungal
infect
thu
clinic
episod
describ
like
caus
agent
respons
sever
pneumonia
recent
describ
bocaviru
respiratori
virus
respiratori
syncyti
viru
hmpv
hbov
seem
preval
etiolog
agent
acut
lower
respiratori
tract
infect
children
recent
evid
human
bocaviru
infect
report
children
year
age
previous
limit
data
adult
includ
immunocompromis
patient
avail
case
describ
support
hypothesi
propos
newli
identifi
respiratori
virus
name
pathogen
also
contribut
sever
infect
adult
patient
high
risk
exampl
hmpv
found
stemcel
transplant
recipi
underw
bal
lower
respiratori
tract
infect
highrisk
patient
hmpv
also
induc
fatal
infect
find
led
conclus
new
viru
induc
ident
clinic
symptom
like
human
bocaviru
may
also
contribut
sever
respiratori
infect
summari
first
report
respiratori
tract
infect
hbov
adult
immunocompromis
patient
strongli
support
assumpt
hbov
emerg
pathogen
requir
attent
even
adult
patient
editor
leishmaniasi
diseas
caus
parasit
genu
leishmania
infect
transmit
human
bite
femal
sandfli
manifest
mainli
form
viscer
cutan
mucocutan
viscer
leishmaniasi
kalaazar
often
fatal
form
diseas
caus
speci
leishmania
donovani
complex
parasit
respons
sever
recent
outbreak
sudan
countri
thought
origin
east
africa
report
describ
success
amplif
l
donovani
dna
ancient
egyptian
christian
nubian
mummi
date
back
year
besid
first
proof
viscer
leishmaniasi
paleopatholog
provid
evid
leishmaniasi
present
nubia
earli
christian
period
organ
also
infect
ancient
egyptian
probabl
close
trade
contact
nubia
middl
kingdom
analyz
bone
tissu
sampl
ancient
egyptian
mummi
skeleton
bone
marrow
sampl
natur
mummifi
human
remain
upper
nubia
egyptian
materi
deriv
preto
earli
dynast
site
abydo
n
bc
middl
kingdom
tomb
thebe
west
bc
differ
tomb
complex
thebe
west
built
use
middl
new
kingdom
late
period
c
bc
nubian
sampl
taken
flood
caus
aswan
dam
earli
christian
burial
site
kulubnarti
second
third
cataract
nile
river
northern
sudan
one
site
island
nile
date
ad
western
bank
nile
use
ad
sampl
test
leishmania
spp
dna
character
direct
sequenc
egyptian
nubian
sampl
fragment
conserv
region
minicircl
molecul
kinetoplastid
mitochondri
dna
parasit
could
success
amplifi
first
primer
pair
unambigu
relat
l
donovani
speci
sequenc
figur
posit
sampl
ancient
egypt
exclus
origin
middl
kingdom
tomb
molecular
evid
ancient
leishmania
dna
found
preto
earli
dynast
new
kingdom
late
period
specimen
middl
kingdom
egyptian
extend
trade
relationship
militari
expedit
nubia
modern
sudan
particular
interest
gold
resourc
countri
obtain
slave
serv
servant
soldier
pharaoh
armi
today
sudan
one
highli
endem
countri
viscer
leishmaniasi
kalaazar
thought
origin
east
africa
later
spread
indian
subcontin
new
world
therefor
high
incid
leishmania
dna
middl
kingdom
sampl
lack
find
earlier
later
time
period
may
indic
leishmaniasi
introduc
egypt
time
leishmaniasi
like
becom
endem
egyptian
nile
valley
diseas
close
link
vector
phlebotomin
sandfli
distribut
acaciabalanit
woodland
ancient
egyptian
becam
infect
close
trade
contact
associ
travel
nubia
middl
kingdom
seem
plausibl
high
frequenc
opinion
express
author
contribut
journal
necessarili
reflect
opinion
center
diseas
control
prevent
institut
author
affili
